Best TWAS P=2.88e-11 · Best GWAS P=3.62e-13 conditioned to 0.000663
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Heart Atrial Appendage | TNRC6A | 0.16 | 0.00 | enet | 21 | 0.01 | 1.8e-01 | 6.0 | -6.2 | 6.8e-10 | 0.25 | 0.09 | 0.10 | TRUE |
2 | METSIM | Adipose | SLC5A11 | 0.23 | 0.28 | lasso | 10 | 0.28 | 1.6e-42 | -5.9 | -5.8 | 6.6e-09 | 0.69 | 0.97 | 0.03 | FALSE |
3 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | SLC5A11 | 0.17 | 0.21 | lasso | 4 | 0.21 | 1.7e-17 | -5.7 | -6.0 | 2.0e-09 | 0.69 | 0.80 | 0.20 | FALSE |
4 | The Cancer Genome Atlas | Breast Invasive Carcinoma | SLC5A11 | 0.12 | 0.17 | enet | 9 | 0.18 | 1.1e-35 | -5.7 | -6.7 | 2.9e-11 | 0.68 | 0.80 | 0.20 | TRUE |
5 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | SLC5A11 | 0.27 | 0.24 | lasso | 6 | 0.24 | 4.5e-12 | -5.8 | -5.8 | 6.1e-09 | 0.66 | 0.80 | 0.20 | FALSE |
6 | The Cancer Genome Atlas | Colon Adenocarcinoma | SLC5A11 | 0.27 | 0.21 | lasso | 2 | 0.20 | 5.2e-12 | -5.8 | -5.8 | 7.0e-09 | 0.69 | 0.77 | 0.23 | FALSE |
7 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | SLC5A11 | 0.13 | 0.15 | enet | 8 | 0.15 | 6.6e-17 | -5.6 | -6.4 | 2.0e-10 | 0.64 | 0.81 | 0.19 | FALSE |
8 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | SLC5A11 | 0.07 | 0.07 | enet | 7 | 0.06 | 1.7e-07 | -5.6 | -6.0 | 2.4e-09 | 0.70 | 0.51 | 0.49 | FALSE |
9 | The Cancer Genome Atlas | Lung Adenocarcinoma | SLC5A11 | 0.14 | 0.20 | enet | 9 | 0.20 | 2.2e-23 | -5.8 | -5.7 | 1.0e-08 | 0.67 | 0.78 | 0.22 | FALSE |
10 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | SLC5A11 | 0.06 | 0.05 | lasso | 1 | 0.05 | 4.9e-06 | -5.8 | -5.8 | 8.6e-09 | 0.69 | 0.33 | 0.61 | FALSE |
11 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | SLC5A11 | 0.30 | 0.33 | lasso | 2 | 0.32 | 2.8e-14 | -5.6 | -5.8 | 9.0e-09 | 0.65 | 0.82 | 0.18 | FALSE |
12 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | SLC5A11 | 0.54 | 0.32 | lasso | 6 | 0.30 | 1.8e-12 | -5.7 | -6.3 | 2.3e-10 | 0.70 | 0.64 | 0.36 | FALSE |
13 | The Cancer Genome Atlas | Prostate Adenocarcinoma | SLC5A11 | 0.26 | 0.28 | lasso | 6 | 0.31 | 1.0e-32 | -5.7 | -6.5 | 8.7e-11 | 0.66 | 0.80 | 0.20 | FALSE |
14 | The Cancer Genome Atlas | Soft Tissue Sarcoma | SLC5A11 | 0.17 | 0.21 | lasso | 3 | 0.18 | 4.9e-11 | -5.6 | -5.5 | 3.0e-08 | 0.67 | 0.81 | 0.19 | FALSE |
15 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | SLC5A11 | 0.20 | 0.05 | lasso | 4 | 0.04 | 2.8e-02 | -5.8 | -5.8 | 6.7e-09 | 0.72 | 0.02 | 0.47 | FALSE |
16 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | SLC5A11 | 0.21 | 0.10 | lasso | 5 | 0.07 | 2.2e-03 | -5.7 | -5.5 | 3.2e-08 | 0.66 | 0.20 | 0.25 | FALSE |
17 | The Cancer Genome Atlas | Thyroid Carcinoma | SLC5A11 | 0.35 | 0.44 | lasso | 4 | 0.44 | 4.2e-47 | -5.7 | -6.0 | 2.2e-09 | 0.69 | 0.84 | 0.16 | FALSE |
18 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | SLC5A11 | 0.24 | 0.15 | lasso | 3 | 0.14 | 1.1e-04 | -5.8 | -5.8 | 8.8e-09 | 0.69 | 0.16 | 0.17 | FALSE |